| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1161/01.STR.0000143318.70292.47 |
| P698 | PubMed publication ID | 15375299 |
| P2093 | author name string | Philip B Gorelick | |
| P433 | issue | 11 Suppl 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| dementia | Q83030 | ||
| vascular dementia | Q583908 | ||
| P304 | page(s) | 2620-2622 | |
| P577 | publication date | 2004-09-16 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Risk factors for vascular dementia and Alzheimer disease | |
| P478 | volume | 35 |
| Q92013778 | A Review of Medical Conditions and Behavioral Problems in Dogs and Cats |
| Q34613047 | APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role? |
| Q37219569 | Aging of perennial cells and organ parts according to the programmed aging paradigm. |
| Q60920274 | Alcohol use and dementia: a systematic scoping review |
| Q64163825 | Alzheimer's Disease: Progress in the Development of Anti-amyloid Disease-Modifying Therapies |
| Q38066233 | Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. |
| Q44408380 | Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients. |
| Q90404112 | An Exploratory Study of Pathways from White Matter Hyperintensities to Cognitive Impairment through Depressive Symptoms Using Structural Equation Modeling: A Cross Sectional Study in Patients with Dementia |
| Q28078881 | Aortic Stiffness, Cerebrovascular Dysfunction, and Memory |
| Q36412999 | Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease |
| Q90255843 | Association between atherosclerosis and Alzheimer's disease: A systematic review and meta-analysis |
| Q35154691 | Association between neovascular age-related macular degeneration and dementia: a population-based case-control study in Taiwan. |
| Q58701393 | Association between white matter lesions and cerebral Aβ burden |
| Q83064220 | Association of estrogen receptor β gene polymorphisms with vascular dementia in women |
| Q34658026 | Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community |
| Q48268027 | Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily. |
| Q53250511 | Atrial fibrillation and risk of dementia in non-demented elderly subjects with and without mild cognitive impairment. |
| Q50675225 | Biomarkers of vascular dysfunction and cognitive decline in patients with Alzheimer's disease: no evidence for association in elderly subjects. |
| Q41660607 | Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease |
| Q38058370 | Blood-brain barrier dysfunction in brain diseases: clinical experience |
| Q37682214 | Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study |
| Q42396970 | CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE. |
| Q37939373 | Can stroke cause neurodegenerative dementia? |
| Q40361355 | Cardiovascular dementia - a different perspective |
| Q36795245 | Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations |
| Q38372164 | Carotid atherosclerosis promotes the progression of Alzheimer's disease: A three-year prospective study |
| Q36136387 | Cerebral amyloidosis: amyloid subunits, mutants and phenotypes. |
| Q46644984 | Cerebral vascular effects of angiotensin II: new insights from genetic models |
| Q92584243 | Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study |
| Q33289262 | Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon |
| Q51900273 | Characterization of the lipid profile in dementia and depression in the elderly. |
| Q34117919 | Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation. |
| Q35626422 | Chronic obstructive pulmonary disease is associated with altered neuropsychological performance in young adults |
| Q34162065 | Clinical correlates of Hachinski ischemic score and vascular factors in cognitive function of elderly. |
| Q34704978 | Cognitive and cerebrovascular improvements following kinin B1 receptor blockade in Alzheimer's disease mice. |
| Q27010423 | Cognitive assessments for the early diagnosis of dementia after stroke |
| Q33354387 | Cognitive function and hypertension |
| Q36824922 | Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden |
| Q34430624 | Cognitive performance after stroke--the Framingham Heart Study |
| Q93059091 | Combinatorial Treatment Using Umbilical Cord Perivascular Cells and Aβ Clearance Rescues Vascular Function Following Transient Hypertension in a Rat Model of Alzheimer Disease |
| Q40126173 | Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression |
| Q37589714 | Comparison of Model-Based Indices of Cerebral Autoregulation and Vasomotor Reactivity Using Transcranial Doppler versus Near-Infrared Spectroscopy in Patients with Amnestic Mild Cognitive Impairment |
| Q47549771 | Correlation study of Framingham risk score and vascular dementia: An observational study |
| Q41597227 | DOCA-salt hypertension impairs artery function in rat middle cerebral artery and parenchymal arterioles |
| Q44405681 | Decreased prevalence of dementia associated with statins: a national population-based study |
| Q33600342 | Decreased serum brain-derived neurotrophic factor levels in elderly korean with dementia |
| Q55286722 | Delusions in Patients with Dementia with Lewy Bodies and the Associated Factors. |
| Q64119747 | Dementia is Associated with an Increased Risk of Hip Fractures: A Nationwide Analysis in Korea |
| Q36750359 | Dementia is associated with open-angle glaucoma: a population-based study |
| Q37077837 | Demographic and clinical characteristics related to cognitive decline in Alzheimer disease in China: A multicenter survey from 2011 to 2014. |
| Q39688862 | Deposition of BACE-1 Protein in the Brains of APP/PS1 Double Transgenic Mice |
| Q30989421 | Determinants of vascular dementia in the Cardiovascular Health Cognition Study. |
| Q37723221 | Diabetes mellitus predicts cognitive impairment in patients with ischemic stroke |
| Q38260539 | Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights. |
| Q34989295 | Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia |
| Q57822469 | Effect of smoking cessation on the risk of dementia: a longitudinal study |
| Q35702415 | Effect of vascular burden as measured by vascular indexes upon vascular dementia: a matched case-control study. |
| Q34655353 | Efficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimen |
| Q33594179 | Electroacupuncture Improves Cognitive Deficits through Increasing Regional Cerebral Blood Flow and Alleviating Inflammation in CCI Rats |
| Q38199061 | Environmental factors in the development and progression of late-onset Alzheimer's disease |
| Q83753613 | Estrogens need insulin-like growth factor I cooperation to exert their neuroprotective effects in post-menopausal women |
| Q39390033 | Ethnic minority, young onset, rare dementia type, depression: A case study of a Muslim male accessing UK dementia health and social care services |
| Q21129438 | Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer's disease |
| Q39931876 | Factor structure of the ARIC-NCS Neuropsychological Battery: An evaluation of invariance across vascular factors and demographic characteristics |
| Q36914115 | Gender differences in dementia risk factors |
| Q35094704 | Genetics of Vascular Dementia |
| Q51887572 | Haemorheological predictors of cognitive decline: the Edinburgh Artery Study. |
| Q31113401 | Hearing Impairment Affects Dementia Incidence. An Analysis Based on Longitudinal Health Claims Data in Germany |
| Q35083074 | Homocysteine and cognitive function in very elderly nondemented subjects |
| Q24202011 | Hyperbaric oxygen therapy for vascular dementia |
| Q24235434 | Hyperbaric oxygen therapy for vascular dementia |
| Q55690406 | Identification of a New Function of Cardiovascular Disease Drug 3-Morpholinosydnonimine Hydrochloride as an Amyloid-β Aggregation Inhibitor. |
| Q30439359 | Impairment in preattentive processing among patients with hypertension revealed by visual mismatch negativity |
| Q48238381 | Increased risk of dementia among chronic osteomyelitis patients |
| Q46367239 | Increased risk of dementia following herpes zoster ophthalmicus |
| Q96304384 | Is there a connection among atrial fibrillation, anticoagulant treatment, and dementia? |
| Q46738149 | Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice |
| Q36822872 | Late-Life Risk Factors for All-Cause Dementia and Differential Dementia Diagnoses in Women: A Prospective Cohort Study. |
| Q51869940 | Left ventricular mass increase is associated with cognitive decline and dementia in the elderly independently of blood pressure. |
| Q50586411 | Lifestyle and Neurocognition in Older Adults With Cardiovascular Risk Factors and Cognitive Impairment. |
| Q34094501 | Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells |
| Q28071869 | Meeting the Challenge of Diabetes in Ageing and Diverse Populations: A Review of the Literature from the UK |
| Q40045531 | Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials |
| Q37022797 | Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study |
| Q37712238 | Model-based quantification of cerebral hemodynamics as a physiomarker for Alzheimer's disease? |
| Q37497635 | Neurosonological Examination: A Non-Invasive Approach for the Detection of Cerebrovascular Impairment in AD. |
| Q36729012 | Nox2 deficiency prevents hypertension-induced vascular dysfunction and hypertrophy in cerebral arterioles |
| Q33317928 | Occupational exposure to extremely low frequency electric and magnetic fields and Alzheimer disease: a meta-analysis |
| Q33677382 | Omega-3 fatty acids and cognitive function in women |
| Q96431764 | PS1 FAD mutants decrease ephrinB2-regulated angiogenic functions, ischemia-induced brain neovascularization and neuronal survival |
| Q46071312 | Perceptions and beliefs about the role of physical activity and nutrition on brain health in older adults. |
| Q38313097 | Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function |
| Q30277872 | Polygenic risk of ischemic stroke is associated with cognitive ability |
| Q50655334 | Portuguese version of Wechsler Memory Scale-3rd edition's utility with demented elderly adults. |
| Q33810246 | Post-stroke cognitive impairment at 3 months |
| Q92054777 | Preventing dementia by preventing stroke: The Berlin Manifesto |
| Q34125853 | Psychiatric disorders and cognitive dysfunction among older, postmenopausal women: results from the Women's Health Initiative Memory Study |
| Q47800613 | Psychotic Symptoms Associated with Poor Renal Function in Mild Cognitive Impairment and Dementias |
| Q58790854 | Rapid and reversible impairment of episodic memory by a high-fat diet in mice |
| Q55251043 | Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease. |
| Q30831782 | Reducing dementia risk by targeting modifiable risk factors in mid-life: study protocol for the Innovative Midlife Intervention for Dementia Deterrence (In-MINDD) randomised controlled feasibility trial |
| Q52381557 | Regional tract-specific white matter hyperintensities are associated with patterns to aging-related brain atrophy via vascular risk factors, but also independently. |
| Q33729956 | Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies |
| Q35141182 | Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease |
| Q37276197 | Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging |
| Q28586383 | Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease |
| Q39874223 | Rural African American clergy: an exploration of their attitudes and knowledge of Alzheimer's disease |
| Q37623424 | Screening for Patients with Mild Alzheimer Disease Using Frequency Doubling Technology Perimetry. |
| Q40164691 | Smoking cessation and Alzheimer's disease: facts, fallacies and promise |
| Q33948757 | Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: a cross-sectional study |
| Q35550689 | The Association between Hypertension and Dementia in the Elderly |
| Q59811244 | The Interaction Effect between Blood Stasis Constitution and Atherosclerotic Factors on Cognitive Impairment in Elderly People |
| Q35096747 | The association of depression, cognitive impairment without dementia, and dementia with risk of ischemic stroke: a cohort study. |
| Q40019277 | The association of transient ischemic attack symptoms with memory impairment among elderly participants of the Third US National Health and Nutrition Examination Survey |
| Q38042547 | The dementia of cardiac disease |
| Q28240201 | The effects of tobacco smoke and nicotine on cognition and the brain |
| Q51952392 | The neuropsychology of vascular dementia. |
| Q36365616 | The thyroid hormone receptor alpha locus and white matter lesions: a role for the clock gene REV-ERBα. |
| Q57621243 | The thyroid hormone receptor α locus and white matter lesions: a role for the clock gene REV-ERBα |
| Q34548586 | Toll-like receptors in Alzheimer's disease |
| Q80349173 | Treatment of vascular dementia: evidence from epidemiologic studies |
| Q99238282 | Tremor in Vascular Cognitive Impairment Raises the Possibility of Mixed Pathology With Lewy Body Disease |
| Q47673606 | Undetected Peripheral Arterial Disease Among Older Adults With Alzheimer's Disease and Other Dementias |
| Q39283416 | Using a biopsychosocial model of dementia as a tool to guide clinical practice |
| Q46547844 | Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study |
| Q26820823 | Vascular aspects of cognitive impairment and dementia |
| Q83194250 | Vascular cognitive impairment |
| Q53339367 | Vascular cognitive impairment. |
| Q33967781 | Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association |
| Q35935418 | Vascular disease burden in Indian subjects with vascular dementia |
| Q34058300 | Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study. |
| Q51889308 | White matter lesion load increases the risk of low CSF Aβ42 in apolipoprotein E-ɛ4 carriers attending a memory clinic. |
| Q53324176 | [Prevention of vascular dementia. Evidence and practice]. |
Search more.